Bioniche Pharma launches generic antiarrhythmic agent
Bioniche Pharma, a developer of injectable pharmaceuticals, has launched ibutilide fumarate injection, the generic equivalent of Pfizer's antiarrhythmic drug Corvert .

Bioniche of Lake Forest, Ill., said it will supply ibutilide fumarate injection in 0.1 mg/mL, 10 mL vials.

The product has a boxed warning relating to proarrhythmic effects including potentially fatal arrhythmias (e.g., polymorphic ventricular tachycardia) and consideration for use in patients with chronic atrial fibrillation.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup